Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus.
Status:
Terminated
Trial end date:
2018-09-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is the prevention of Staphylococcus aureus pneumonia in
mechanically ventilated subjects heavily colonized with S. aureus. Staphylococcus aureus is a
human pathogenic bacterium that causes severe infections, including pneumonia and sepsis.
Hospital-acquired bacterial pneumonia (HABP) caused by S. aureus, including
ventilator-associated bacterial pneumonia (VABP) in mechanically ventilated subjects, is a
significant public health threat despite efforts to optimize antibiotic treatment. ASN100 is
an investigational monoclonal antibody product that targets the toxins produced by S. aureus
to protect subjects from developing S. aureus pneumonia.